Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.18 USD | -0.84% | -1.33% | -13.96% |
03:25pm | Everlasting momentum | |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.96% | 90.31B | |
+32.89% | 709B | |
+30.77% | 595B | |
-1.82% | 367B | |
+20.24% | 334B | |
+5.91% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.04% | 171B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- William Blair Downgrades Bristol-Myers Squibb to Market Perform From Outperform